FFCP PHASE2:Hg19::chr2:203160480..203160512,+
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p@chr2:203160480..203160512, + |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_at_chr2:203160480..203160512, + |
| Coexpression cluster: | C483_acute_diffuse_medulloblastoma_hepatocellular_small_mesothelioma_testicular |
| Association with transcript: | NA |
| EntrezGene: | NA |
| HGNC: | NA |
| UniProt: | NA |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p@chr2:203160480..203160512+ |
|---|
0
5
10
15
20
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| disease of cellular proliferation | 1.28e-45 | 239 |
| cancer | 2.29e-44 | 235 |
| cell type cancer | 7.49e-25 | 143 |
| carcinoma | 1.49e-20 | 106 |
| organ system cancer | 2.19e-17 | 137 |
| hematologic cancer | 5.80e-16 | 51 |
| immune system cancer | 5.80e-16 | 51 |
| leukemia | 1.23e-12 | 39 |
| myeloid leukemia | 3.25e-09 | 31 |
Showing 1 to 9 of 9 entries
